Celgene Corporation
Aug 26, 2015
PDF
Add to Briefcase

Celgene Corporation to Webcast Upcoming Investor Conferences in September

SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) plans to present at three upcoming investor conferences in September where Celgene management will provide an overview of the Company. The conferences will be webcast live and a link to the webcast will be available in the Investor Relations section of the Company's website at www.celgene.com.

Wednesday, September 9, 2015 at Baird's 2015 Healthcare Conference in New York City at 3:45 pm ET

Wednesday, September 16, 2015 at the 2015 Morgan Stanley Global Healthcare Conference in New York City at 1:40 pm ET

Thursday, September 17, 2015 at the 2015 Bank of America Merrill Lynch Global Healthcare Conference in London at 8 am ET

About Celgene

Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit www.celgene.com. Follow Celgene on Social Media: @Celgene, Pinterest, LinkedIn and YouTube.

Forward-Looking Statements

This press release contains forward-looking statements, which are generally statements that are not historical facts. Forward-looking statements can be identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans," "will," "outlook" and similar expressions. Forward-looking statements are based on management's current plans, estimates, assumptions and projections, and speak only as of the date they are made. We undertake no obligation to update any forward-looking statement in light of new information or future events, except as otherwise required by law. Forward-looking statements involve inherent risks and uncertainties, most of which are difficult to predict and are generally beyond our control. Actual results or outcomes may differ materially from those implied by the forward-looking statements as a result of the impact of a number of factors, many of which are discussed in more detail in our Annual Report on Form 10-K and our other reports filed with the Securities and Exchange Commission.

Celgene Corporation
Patrick E. Flanigan III, 908-673-9969
VP, Investor Relations
or
Brian Gill, 908-673-9530
VP, Corporate Communications

Source: Celgene Corporation

News Provided by Acquire Media